Verified Insights
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
+91 9425150513 (Asia) support@24lifesciences.com
+91 9425150513 (Asia) support@24lifesciences.com
Download Sample Pdf
MARKET INSIGHTS
Global Cardiovascular Intravenous Indwelling Needles market size was valued at USD 780.4 million in 2024. The market is projected to grow from USD 832.1 million in 2025 to USD 1.26 billion by 2032, exhibiting a CAGR of 6.1% during the forecast period.
Cardiovascular intravenous indwelling needles, also known as peripheral intravenous catheters (PIVCs) or angiocatheters, are essential medical devices used for vascular access. These devices, typically made of materials like polyurethane (PU) or fluorinated ethylene propylene (FEP), facilitate the administration of fluids, medications, and blood products directly into a patient's bloodstream. They are critical across a wide spectrum of cardiovascular procedures, from routine hydration to complex drug delivery during cardiac events.
The market is experiencing steady growth driven by several key factors. The global medical devices market, estimated at USD 603 billion in 2023, provides a strong foundation, growing at a projected CAGR of 5% for the next six years. This expansion is primarily fueled by the rising global prevalence of cardiovascular diseases (CVDs), the growing geriatric population who are more susceptible to such conditions, and the overall increase in surgical volumes worldwide. Furthermore, technological advancements focused on improving patient safety, such as safety-engineered designs to reduce needlestick injuries and antimicrobial coatings to prevent bloodstream infections, are significant contributors to market expansion. Leading players like B. Braun, Terumo, and Cardinal Health continuously innovate and expand their product portfolios to capture market share in this competitive landscape.
Rising Global Burden of Cardiovascular Diseases
The increasing prevalence of cardiovascular diseases (CVDs) such as coronary artery disease, heart failure, and arrhythmias is a primary driver for the cardiovascular intravenous indwelling needle market. The World Health Organization identifies CVDs as the leading cause of death globally, necessitating a high volume of diagnostic and therapeutic procedures like angiograms, stent placements, and drug infusions, all of which rely on reliable vascular access.
Advancements in Safety and Material Technology
Continuous innovation in needle design and materials is significantly driving market growth. The shift towards safety-engineered devices with features like passive safety mechanisms, retractable needles, and catheters made from advanced polymers reduces the risk of needlestick injuries and improves patient comfort. The adoption of antimicrobial-coated catheters also helps to lower the incidence of catheter-related bloodstream infections, a major concern in hospital settings.
➤ The global push for improved patient safety protocols and stringent regulations mandating the use of safety-engineered devices in healthcare facilities is creating a sustained demand for advanced intravenous indwelling needles.
Furthermore, the expansion of minimally invasive surgical procedures and the growing number of hospitals and ambulatory surgical centers worldwide are contributing to the steady uptake of these essential medical devices.
MARKET CHALLENGES
High Cost of Advanced Safety Devices
A significant challenge facing the market is the higher cost associated with advanced safety-engineered intravenous indwelling needles compared to conventional products. This creates a financial barrier for widespread adoption, particularly in cost-sensitive markets and developing regions with limited healthcare budgets. Hospitals and clinics must balance the benefits of enhanced safety with the substantial impact on operational expenses.
Other Challenges
Risk of Complications
Despite technological improvements, complications such as phlebitis, infiltration, and infection remain a challenge, requiring continuous training for healthcare professionals and diligent patient monitoring, which adds to the overall cost of care.
Regulatory Hurdles
Stringent regulatory approval processes for new medical devices can delay product launches and increase development costs for manufacturers, potentially slowing down the pace of innovation in the market.
Price Pressure and Reimbursement Issues
Intense price competition among manufacturers and growing pressure from group purchasing organizations (GPOs) are key restraints on market revenue growth. Additionally, variability in reimbursement policies for medical procedures and devices across different regions and insurance providers can limit the adoption of premium-priced, advanced indwelling needles, favoring cheaper alternatives.
Expansion in Emerging Economies
Emerging economies in Asia-Pacific, Latin America, and the Middle East present substantial growth opportunities. Rising healthcare expenditure, improving healthcare infrastructure, and growing awareness of advanced medical technologies in these regions are expected to drive demand. Manufacturers can capitalize on this by offering products tailored to the specific needs and price points of these markets.
Integration with Digital Health Platforms
The integration of intravenous indwelling devices with digital health technologies, such as smart catheters equipped with sensors to monitor vital signs or catheter placement, represents a significant frontier for innovation. This convergence can improve patient outcomes through real-time data monitoring and pave the way for more personalized patient care, creating a new revenue stream for market players.
Segment Analysis:| Segment Category | Sub-Segments | Key Insights |
| By Type |
|
PU is the dominant segment due to its superior material properties, including excellent biocompatibility, flexibility, and durability, which are critical for long-term indwelling applications in cardiovascular procedures. This material's stability and reduced risk of thrombogenicity make it the preferred choice for manufacturers and clinicians, supporting its leading market position over alternative materials. The segment benefits from established manufacturing processes and widespread clinical acceptance. |
| By Application |
|
Hospital is the leading application segment, driven by the high volume of complex cardiovascular procedures, emergency interventions, and critical care that require reliable vascular access. Hospitals' comprehensive infrastructure, availability of specialized medical personnel, and the need for continuous patient monitoring create substantial demand for these needles. The concentration of advanced diagnostic and therapeutic facilities in hospital settings solidifies this segment's dominance over clinics and other outpatient care centers. |
| By End User |
|
Geriatric represents the leading end-user segment, as this population demographic experiences a significantly higher prevalence of cardiovascular diseases, chronic conditions, and age-related vascular complications necessitating frequent medical interventions. The growing global geriatric population drives consistent demand for reliable intravenous access devices for medication administration, fluid management, and diagnostic procedures, making this segment a key focus for market participants. |
| By Needle Gauge |
|
Medium Gauge needles hold a prominent position in the market, offering an optimal balance between patient comfort and clinical functionality for a wide range of cardiovascular applications, including routine infusions and contrast agent administration. Their versatility makes them suitable for both adult and pediatric patients, supporting their widespread adoption across various clinical settings and contributing to their leadership in this segmentation category. |
| By Product Design |
|
Safety Needles are the leading segment by product design, propelled by stringent regulatory mandates and a heightened focus on healthcare worker safety to prevent needlestick injuries. These advanced designs incorporate safety mechanisms that reduce the risk of accidental puncture, aligning with global occupational safety standards and hospital protocols. This enhanced safety profile is a critical purchasing criterion, driving preference over conventional designs. |
A Market Characterized by Global Leaders and Strategic Regional Focus
The global Cardiovascular Intravenous Indwelling Needles market features a competitive environment dominated by a few established multinational corporations. Terumo Corporation and B. Braun Melsungen AG are widely recognized as leaders, holding significant market shares. Their dominance is driven by extensive product portfolios, strong brand recognition, global distribution networks, and substantial investment in research and development for advanced safety and material technologies. Following closely are other major players like Medtronic, Boston Scientific, and Cardinal Health, which leverage their broad presence across various cardiovascular and medical device segments to compete effectively. The competitive strategies primarily revolve around product innovation, particularly in needle safety features and catheter materials like PU and FEP, strategic mergers and acquisitions, and expanding market reach in high-growth regions.
Beyond the top-tier global players, the market includes several significant companies that hold strong positions in specific geographic regions or product niches. Companies such as Merit Medical and COOK Medical have established a strong reputation for specialized vascular access devices. Furthermore, the Asia-Pacific region, particularly China, has seen the emergence of influential domestic manufacturers. Companies like Shandong Weigao Group, Zhejiang Sujia Medical Device, and Shanghai Shangyi Kangge Medical Equipment have grown substantially by catering to the large and rapidly expanding local healthcare markets, often competing on price and regional supply chain advantages. These players are increasingly focusing on improving product quality and expanding their footprint both domestically and internationally.
List of Key Cardiovascular Intravenous Indwelling Needles Companies ProfiledBoston Scientific Corporation
Cardinal Health, Inc.
Merit Medical Systems, Inc.
Delta Med
PRODIMED
Biotronic
Zhejiang Sujia Medical Device Co., Ltd
Shanghai Shangyi Kangge Medical Equipment Co., Ltd
Yangzhou Kanglilai Medical Device Co., Ltd
Shandong Weigao Group Medical Polymer Co. Limited
Shandong Xinhua Medical Device Co., Ltd
The global Cardiovascular Intravenous Indwelling Needles market is on a steady growth trajectory, driven by the overall expansion of the medical devices sector, which is projected to grow at a CAGR of 5% in the coming years. A primary driver for this market is the rising global healthcare expenditure, which now constitutes approximately 10% of the global GDP. This sustained investment is largely a response to the health needs of an aging population, the increasing prevalence of chronic and infectious diseases requiring vascular access, and the expansion of healthcare services in emerging markets. The demand for advanced, reliable vascular access devices like indwelling needles is directly linked to the volume of medical procedures performed in hospitals and clinics worldwide.
Other TrendsDominance of Hospital and Clinic Applications
Cardiovascular intravenous indwelling needles are primarily utilized in hospital and clinical settings, which represent the largest application segment. The consistent demand from these facilities underscores the critical role these devices play in routine and critical care, including fluid administration, medication delivery, and blood sampling. The high patient throughput in hospitals ensures a continuous need for these essential medical devices.
Material Innovation and Product Segmentation
The market is segmented by material type, with PU (Polyurethane) and FEP (Fluorinated Ethylene Propylene) being the primary categories. Each material offers distinct advantages in terms of flexibility, biocompatibility, and resistance to kinking, catering to different clinical requirements and durations of use. Manufacturers are continuously engaged in research and development to enhance material properties, aiming to improve patient comfort and reduce complications such as phlebitis.
Competitive Landscape and Regional DynamicsThe global market features a mix of established international players and regional manufacturers. Key companies such as Terumo, B. Braun, and Medtronic hold significant market share, competing on product innovation, reliability, and distribution networks. Geographically, North America and Europe are mature markets with high adoption rates of advanced medical technologies, while the Asia-Pacific region is expected to exhibit substantial growth potential due to improving healthcare infrastructure and increasing medical procedure volumes in countries like China and India.
Regional Analysis: Cardiovascular Intravenous Indwelling Needles MarketEurope
Europe represents a mature and highly regulated market for Cardiovascular Intravenous Indwelling Needles, characterized by robust public healthcare systems and a strong focus on cost-effectiveness and patient safety standards governed by the MDR. Countries like Germany, France, and the United Kingdom are primary drivers, with their advanced medical facilities and high adoption rates of medical technologies. The market benefits from well-established procurement processes within national health services and a growing emphasis on outpatient care, which increases the demand for reliable vascular access devices. The presence of a large geriatric population susceptible to cardiovascular conditions ensures a steady demand. However, pricing pressures from government healthcare systems can sometimes slow the adoption of the most expensive advanced products compared to North America.
Asia-Pacific
The Asia-Pacific region is experiencing the most rapid growth in the Cardiovascular Intravenous Indwelling Needles market, fueled by expanding healthcare infrastructure, rising healthcare expenditure, and increasing awareness of advanced medical treatments. Large populations in countries like China, India, and Japan, combined with a growing burden of cardiovascular diseases, create a massive potential patient base. Governments are investing heavily in upgrading public hospitals, which is broadening access to procedures requiring indwelling needles. The market is characterized by a mix of low-cost local manufacturers and the expanding presence of multinational corporations aiming to capture this high-growth market. Price sensitivity remains a significant factor, driving demand for both standard and value-engineered products.
South America
The South American market for Cardiovascular Intravenous Indwelling Needles is developing, with growth primarily concentrated in larger economies such as Brazil and Argentina. Market expansion is supported by gradual improvements in public and private healthcare infrastructure and increasing investments in medical technology. Economic volatility and budgetary constraints within public health systems can, however, impact the pace of adoption for premium products. The focus is often on acquiring reliable and cost-effective devices to meet the basic and growing needs of vascular access for cardiac care. The market shows potential for growth as healthcare access continues to improve across the region.
Middle East & Africa
The Middle East & Africa region presents a diverse and evolving market landscape. Wealthier Gulf Cooperation Council countries, with their modern healthcare facilities and high per capita spending, drive the adoption of advanced Cardiovascular Intravenous Indwelling Needles, similar to Western standards. In contrast, other parts of the region face challenges related to healthcare infrastructure and accessibility, which limit market penetration. The overall market growth is supported by government initiatives to improve healthcare services and a rising prevalence of lifestyle-related cardiovascular diseases. The region is characterized by a significant disparity in product adoption between high-income and low-income countries.
This market research report offers a holistic overview of global and regional markets for the forecast period 2025–2032. It presents accurate and actionable insights based on a blend of primary and secondary research.
✅ Market Overview
Global and regional market size (historical & forecast)
Growth trends and value/volume projections
✅ Segmentation Analysis
By product type or category
By application or usage area
By end-user industry
By distribution channel (if applicable)
✅ Regional Insights
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country-level data for key markets
✅ Competitive Landscape
Company profiles and market share analysis
Key strategies: M&A, partnerships, expansions
Product portfolio and pricing strategies
✅ Technology & Innovation
Emerging technologies and R&D trends
Automation, digitalization, sustainability initiatives
Impact of AI, IoT, or other disruptors (where applicable)
✅ Market Dynamics
Key drivers supporting market growth
Restraints and potential risk factors
Supply chain trends and challenges
✅ Opportunities & Recommendations
High-growth segments
Investment hotspots
Strategic suggestions for stakeholders
✅ Stakeholder Insights
This report is designed to support strategic decision-making for a wide range of stakeholders, including:
Medical device manufacturers
Healthcare providers and hospital systems
Contract research organizations
Investors and consultancy firms
Policy makers and regulatory bodies
-> Global cardiovascular intravenous indwelling needles market was valued at USD 780.4 million in 2024 and is expected to reach USD 1.26 billion by 2032.
-> Key players include Terumo, B.Braun, Cardinal Health, Medtronic, and Boston Scientific, among others.
-> Key growth drivers include rising prevalence of cardiovascular diseases, increasing geriatric population, and technological advancements in needle safety.
-> North America currently leads the market, while Asia-Pacific shows the highest growth potential.
-> Emerging trends include safety-engineered designs, antimicrobial coatings, and innovative materials like fluorinated ethylene propylene.
Our Clients
“The data provided by 24LifeScience was clear, well-organized, and useful for internal strategy planning. It helped us understand the competitive landscape more effectively.”
“We used one of their market overview reports for early-stage feasibility work. It gave us a helpful snapshot of current trends and key players in our therapeutic area.”
“I appreciated the team’s responsiveness and willingness to adjust the scope based on our feedback. The final report was aligned with our expectations and timelines.”
“Their custom report on clinical trial trends was a helpful reference as we explored new indications."
“As someone working on early product planning, I found their therapeutic area briefs quite useful. The information was presented in a way that made it easy to extract key takeaways.”
“We didn’t need anything overly complex—just solid, dependable data. 24LifeScience delivered exactly that, without unnecessary fluff.”
“Their reports gave us a good foundation to start our own market assessment. While we supplemented it with other data, this was a great starting point.”
“I’ve used a few of their reports for academic and grant writing purposes. They’re generally well-cited and reliable for understanding market scope.”
At 24LifeScience, we combine domain expertise with dependable research delivery. What truly differentiates us isn't just what we do — it's how we do it. Our clients trust us because we offer consistency, security, value, and most importantly, insight that drives action.
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
We uphold rigorous data validation processes to ensure every report is reliable, up-to-date, and based on credible sources.
24LifeScience powers research for top firms in 20+ nations.Chosen by leading life sciences companies worldwide.
We offer competitive pricing models that align with your project scope — no hidden charges, no lock-in. Tailored pricing for every scale and need.
8–10+ years of life sciences expertise turned into strategic insights.We don’t just summarize data we contextualize it.
Whether it's a ready-made report or a custom project, we deliver within the promised timeline With real-time updates